BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT00633529-completion@plaintrial.com
DTSTAMP:20261027T185549Z
DTSTART;VALUE=DATE:201103
SUMMARY:Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Tr
 eatment for Patients With NSCLC — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT00633529
URL:https://plaintrial.com/trial/NCT00633529
END:VEVENT
END:VCALENDAR